Use of IRS-polypeptides for identifying of pharmaceutically active compounds

US7732151B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Norbert Tennagels · Siegburg, DE
• Aimo Kannt · Dreieich, DE
• Harald Thuering · Frankfurt, DE

Key dates

• Filing date: May 19, 2004
• Grant date: Jun 8, 2010
• Expiry date: Dec 27, 2025

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2500/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An assay for determining the ability of an enzyme, functional fragment, or functional derivative thereof to modify the phosphorylation status of a biotinylated polypeptide.